Thrombocytopenia: all 703 studies

Page 3 of 8. Open to participants first (151), then studies with results posted, then the rest; newest registration first within each.

• Eltrombopag With Standard Immunosuppression for Severe Aplastic AnemiaActive, not recruitingNCT01623167Phase 1/2Results posted
• The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)CompletedNCT01566695Phase 3Results posted
• Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT01529827Phase 2Results posted
• Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.CompletedNCT01520909Phase 3Results posted
• Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple MyelomaTerminatedNCT01484314Phase 2Results posted
• Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric PatientsCompletedNCT01444417Phase 3Results posted
• A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid LeukemiaCompletedNCT01440374Phase 2Results posted
• Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)CompletedNCT01438840Phase 3Results posted
• Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase TherapyCompletedNCT01428635Phase 2/3Results posted
• Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study)TerminatedNCT01368211Phase 2/3Results posted
• Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501CompletedNCT01355289Phase 2Results posted
• Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune ThrombocytopeniaCompletedNCT01349790Phase 3Results posted
• Eltrombopag for Moderate Aplastic AnemiaCompletedNCT01328587Phase 2Results posted
• Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type IICompletedNCT01304238Results posted
• Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes StudyCompletedNCT01178333Results posted
• Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic SyndromeCompletedNCT01165996Phase 1/2Results posted
• Safety and Efficacy Study for Solid Tumor Patients Treated With EltrombopagCompletedNCT01147809Phase 2Results posted
• Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving RomiplostimCompletedNCT01143038Phase 2Results posted
• Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related DiseaseCompletedNCT01133860Phase 2Results posted
• An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)TerminatedNCT01129024Phase 2Results posted
• A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia PurpuraCompletedNCT01071954Phase 3Results posted
• A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)TerminatedNCT01054443Phase 2Results posted
• Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCTCompletedNCT01012492Phase 2Results posted
• Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT01002755Phase 2Results posted
• Eltrombopag for Post Transplant ThrombocytopeniaCompletedNCT01000051Phase 2Results posted
• Safety and Efficacy Study of Sirolimus in Complicated Vascular AnomaliesCompletedNCT00975819Phase 2Results posted
• A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)CompletedNCT00961064Phase 2Results posted
• Study of the Effect of Differing Platelet Transfusion Times in NeonatesCompletedNCT00948792Not applicableResults posted
• A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary MyelofibrosisTerminatedNCT00931762Phase 2Results posted
• A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia PatientsCompletedNCT00922883Phase 2Results posted
• Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic ProceduresCompletedNCT00914927Phase 2Results posted
• Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) PatientsTerminatedNCT00909363Phase 2Results posted
• Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00908037Phase 2Results posted
• Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)CompletedNCT00907478Phase 4Results posted
• Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body IrradiationCompletedNCT00903929Phase 1Results posted
• Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00902018Phase 2Results posted
• Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced ThrombocytopeniaTerminatedNCT00886743Phase 2Results posted
• A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis SyndromeTerminatedNCT00787332Phase 4Results posted
• Platelet Count Trends in Pre-eclamptic ParturientsCompletedNCT00787241Results posted
• Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal CancerCompletedNCT00771810Phase 2Results posted
• Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive ProceduresTerminatedNCT00678587Phase 3Results posted
• Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)TerminatedNCT00673439Phase 2Results posted
• TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TBCompletedNCT00664313Phase 1/2Results posted
• Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)CompletedNCT00614523Phase 2Results posted
• Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)TerminatedNCT00594685Results posted
• Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic SyndromeTerminatedNCT00589316Phase 1Results posted
• Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and HormonesTerminatedNCT00556400Phase 1/2Results posted
• Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric SubjectsCompletedNCT00515203Phase 1/2Results posted
• An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITPCompletedNCT00508820Phase 3Results posted
• Aspirin in Patients With Myocardial Infarction and ThrombocytopeniaTerminatedNCT00501345Phase 3Results posted
• Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) PatientsCompletedNCT00493181Phase 2Results posted
• Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)CompletedNCT00472290Not applicableResults posted
• Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)CompletedNCT00454857Results posted
• A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving RevlimidCompletedNCT00418665Phase 2Results posted
• Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic PurpuraCompletedNCT00415532Phase 3Results posted
• Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00413283Phase 2Results posted
• Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With ThrombosisCompletedNCT00412464Phase 1Results posted
• Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative DisordersCompletedNCT00397813Phase 2Results posted
• Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating AgentsCompletedNCT00321711Phase 2Results posted
• Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)CompletedNCT00303472Phase 2Results posted
• Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic DisordersCompletedNCT00301834Phase 2Results posted
• A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With LymphomaCompletedNCT00283439Phase 1/2Results posted
• Three Immunosuppressive Treatment Regimens for Severe Aplastic AnemiaCompletedNCT00260689Phase 2Results posted
• Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory CytopeniasCompletedNCT00244010Not applicableResults posted
• Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-InfectionTerminatedNCT00239733Phase 4Results posted
• A Trial of Antenatal Treatment of Alloimmune ThrombocytopeniaCompletedNCT00194987Phase 2/3Results posted
• Optimal Platelet Dose Strategy for Management of ThrombocytopeniaCompletedNCT00128713Phase 3Results posted
• Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)CompletedNCT00116688Phase 3Results posted
• Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment RegimenTerminatedNCT00074165Phase 2Results posted
• Safety of Anticoagulation Therapy in Cirrhotic Patients With PVT and Severe ThrombocytopeniaCompletedNCT07885969
• Observational Study on Eltrombopag in Hypocellular Myelodysplastic NeoplasmsActive, not recruitingNCT07825207
• Effect of Rifaximin on Thrombocytopenia in Patients With HCV-Related Liver CirrhosisCompletedNCT07791940Phase 4
• Retrospective Study of Romiplostim for Platelet Engraftment After Allo-HSCTCompletedNCT07747246
• Avatrombopag for Severe Thrombocytopenia After Liver Transplantation: A Retrospective Cohort StudyCompletedNCT07600905
• A Study to Evaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective ProcedureCompletedNCT07446491Phase 1/2
• Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive TransfusionCompletedNCT07290634
• Comparative Study of Thrombocytopenia in Plasmodium Vivax and Falciparum MalariaCompletedNCT07122232
• Unravelling the Role of Apoptosis in Platelets Biogenesis Through the Study of the Thrombocytopenia THC4Active, not recruitingNCT07026578
• 177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and CytopeniaWithdrawnNCT07025512Phase 2
• Predicting Platelet Count From Viscoelastic TestingActive, not recruitingNCT06870851
• Collection of Peripheral Blood From Patients With Hematologic Malignancies With ThrombocytopeniaCompletedNCT06824727
• Bioequivalence Test of Eltrombopag Olamine Tablets in Humans Under Fasting StateCompletedNCT06768632Not applicable
• Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed StateCompletedNCT06768619Not applicable
• Compare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal FunctionCompletedNCT06761131
• Analysis of Biological Progression and Regression of HELLP Syndrome in TimeCompletedNCT06758960
• Study on the Efficacy and Safety of Avatricopal in Patients With CLD Complicated With ThrombocytopeniaCompletedNCT06642740
• Efficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue PatientsActive, not recruitingNCT06642493Not applicable
• Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)Active, not recruitingNCT06594146Phase 2
• Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery PatientsCompletedNCT06565364
• A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation.CompletedNCT06534255Phase 1
• A Study of PN20 in Healthy Adult VolunteersCompletedNCT06523088Phase 1
• A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor PatientsCompletedNCT06521931Phase 1
• Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune ThrombocytopeniaActive, not recruitingNCT06497036Phase 3
• Efficacy and Safety of Eltrombopag for Refractory Thrombocytopenia Associated With Connective Tissue DiseaseCompletedNCT06458803
• Interpretability of the Quantra® Viscoelastic Test in Patients with Haematological Malignancies with Profound Thrombocytopenia Below 50x10 G/L.CompletedNCT06455553Not applicable
• Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in EuropeCompletedNCT06408324
• The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)WithdrawnNCT06291415Phase 1
• Outcome Study of Conventional Steroids Vs. Steroids Combined with Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura.CompletedNCT06288932Phase 3
• Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.Active, not recruitingNCT06276036Not applicable
• A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune ThrombocytopeniaActive, not recruitingNCT06199089Phase 2

← Thrombocytopenia overview